312 related articles for article (PubMed ID: 29126570)
1. Genomics-Driven Natural Product Discovery in Actinomycetes.
Niu G
Trends Biotechnol; 2018 Mar; 36(3):238-241. PubMed ID: 29126570
[TBL] [Abstract][Full Text] [Related]
2. Heterologous expression-facilitated natural products' discovery in actinomycetes.
Xu M; Wright GD
J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):415-431. PubMed ID: 30446891
[TBL] [Abstract][Full Text] [Related]
3. Natural products discovery from micro-organisms in the post-genome era.
Ikeda H
Biosci Biotechnol Biochem; 2017 Jan; 81(1):13-22. PubMed ID: 27885932
[TBL] [Abstract][Full Text] [Related]
4. Natural product discovery: past, present, and future.
Katz L; Baltz RH
J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):155-76. PubMed ID: 26739136
[TBL] [Abstract][Full Text] [Related]
5. Ecology and genomics of Actinobacteria: new concepts for natural product discovery.
van Bergeijk DA; Terlouw BR; Medema MH; van Wezel GP
Nat Rev Microbiol; 2020 Oct; 18(10):546-558. PubMed ID: 32483324
[TBL] [Abstract][Full Text] [Related]
6. Discovery of phosphonic acid natural products by mining the genomes of 10,000 actinomycetes.
Ju KS; Gao J; Doroghazi JR; Wang KK; Thibodeaux CJ; Li S; Metzger E; Fudala J; Su J; Zhang JK; Lee J; Cioni JP; Evans BS; Hirota R; Labeda DP; van der Donk WA; Metcalf WW
Proc Natl Acad Sci U S A; 2015 Sep; 112(39):12175-80. PubMed ID: 26324907
[TBL] [Abstract][Full Text] [Related]
7. Challenges and triumphs to genomics-based natural product discovery.
Jensen PR; Chavarria KL; Fenical W; Moore BS; Ziemert N
J Ind Microbiol Biotechnol; 2014 Feb; 41(2):203-9. PubMed ID: 24104399
[TBL] [Abstract][Full Text] [Related]
8. Culturable rare Actinomycetes: diversity, isolation and marine natural product discovery.
Subramani R; Aalbersberg W
Appl Microbiol Biotechnol; 2013 Nov; 97(21):9291-321. PubMed ID: 24057404
[TBL] [Abstract][Full Text] [Related]
9. Renaissance in antibacterial discovery from actinomycetes.
Baltz RH
Curr Opin Pharmacol; 2008 Oct; 8(5):557-63. PubMed ID: 18524678
[TBL] [Abstract][Full Text] [Related]
10. Rare actinomycetes: a potential storehouse for novel antibiotics.
Tiwari K; Gupta RK
Crit Rev Biotechnol; 2012 Jun; 32(2):108-32. PubMed ID: 21619453
[TBL] [Abstract][Full Text] [Related]
11. Renewed interests in the discovery of bioactive actinomycete metabolites driven by emerging technologies.
Ossai J; Khatabi B; Nybo SE; Kharel MK
J Appl Microbiol; 2022 Jan; 132(1):59-77. PubMed ID: 34265147
[TBL] [Abstract][Full Text] [Related]
12. Ecological Strategies Behind the Selection of Cultivable Actinomycete Strains from the Yucatan Peninsula for the Discovery of Secondary Metabolites with Antibiotic Activity.
Parera-Valadez Y; Yam-Puc A; López-Aguiar LK; Borges-Argáez R; Figueroa-Saldivar MA; Cáceres-Farfán M; Márquez-Velázquez NA; Prieto-Davó A
Microb Ecol; 2019 May; 77(4):839-851. PubMed ID: 30761424
[TBL] [Abstract][Full Text] [Related]
13. Genome-guided Investigation of Antibiotic Substances produced by Allosalinactinospora lopnorensis CA15-2(T) from Lop Nor region, China.
Huang C; Leung RK; Guo M; Tuo L; Guo L; Yew WW; Lou I; Lee SMY; Sun C
Sci Rep; 2016 Feb; 6():20667. PubMed ID: 26864220
[TBL] [Abstract][Full Text] [Related]
14. Genome-based bioprospecting of microbes for new therapeutics.
Zotchev SB; Sekurova ON; Katz L
Curr Opin Biotechnol; 2012 Dec; 23(6):941-7. PubMed ID: 22560158
[TBL] [Abstract][Full Text] [Related]
15. Next Generation Sequencing of Actinobacteria for the Discovery of Novel Natural Products.
Gomez-Escribano JP; Alt S; Bibb MJ
Mar Drugs; 2016 Apr; 14(4):. PubMed ID: 27089350
[TBL] [Abstract][Full Text] [Related]
16. A roadmap for natural product discovery based on large-scale genomics and metabolomics.
Doroghazi JR; Albright JC; Goering AW; Ju KS; Haines RR; Tchalukov KA; Labeda DP; Kelleher NL; Metcalf WW
Nat Chem Biol; 2014 Nov; 10(11):963-8. PubMed ID: 25262415
[TBL] [Abstract][Full Text] [Related]
17. Natural product drug discovery in the genomic era: realities, conjectures, misconceptions, and opportunities.
Baltz RH
J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):281-299. PubMed ID: 30484124
[TBL] [Abstract][Full Text] [Related]
18. Natural Products and the Gene Cluster Revolution.
Jensen PR
Trends Microbiol; 2016 Dec; 24(12):968-977. PubMed ID: 27491886
[TBL] [Abstract][Full Text] [Related]
19. Applications and Restrictions of Integrated Genomic and Metabolomic Screening: An Accelerator for Drug Discovery from Actinomycetes?
Krause J
Molecules; 2021 Sep; 26(18):. PubMed ID: 34576921
[TBL] [Abstract][Full Text] [Related]
20. Cryptic or Silent? The Known Unknowns, Unknown Knowns, and Unknown Unknowns of Secondary Metabolism.
Hoskisson PA; Seipke RF
mBio; 2020 Oct; 11(5):. PubMed ID: 33082252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
